Oncology MSL: Rare Disease & Immunology

Syneos Health, Inc.; Atlanta (GA); On-site; USD 210,000 - 220,000; Full time

Benefits offered by this job

Health benefits

Company 401k match

Paid time off

Sick time

Job summary

Syneos Health is seeking an experienced Medical Science Liaison in Rare Disease/Immunology based in Atlanta, GA. The role focuses on scientific exchange with key opinion leaders, internal stakeholders, and integration of clinical data to inform practice.

You will engage with HCPs, translate complex data for real-world use, and support medical affairs strategies while traveling up to 60% as needed to collaborate across teams and sites.

Qualifications

• Advanced scientific degree (MD, PhD, PharmD, NP, PA).
• 3+ years industry experience as an MSL.
• Oncology experience preferred.
• Immunology, Infectious Disease, or Rare Disease experience preferred.
• Strong scientific and clinical acumen.
• Willingness to travel up to 60% with valid drivers license.

Responsibilities

• Provide compliant scientific responses to medical information requests.
• Senior subject matter expert to internal and external stakeholders.
• Establish and maintain scientific relationships with HCPs.
• Translate scientific data into real-world clinical practice.
• Support customer-centric tactical engagement plans for Medical Affairs.
• Maintain knowledge base with current literature and trends.
• Collaborate with field medical and commercial colleagues.
• Share medical insights to enable internal/external research communications.

Skills

MSL experience

Thought leader engagement

Scientific communication

Travel readiness

Education

MD/PhD/PharmD/NP/PA

Job description

Syneos Health is seeking an experienced Medical Science Liaison in Rare Disease/Immunology based in Atlanta, GA. The role focuses on scientific exchange with key opinion leaders, internal stakeholders, and integration of clinical data to inform practice.

You will engage with HCPs, translate complex data for real-world use, and support medical affairs strategies while traveling up to 60% as needed to collaborate across teams and sites.